Central adrenal insufficiency screening with morning plasma cortisol and ACTH levels in Prader–Willi syndrome
Author:
Angulo Moris A.1, Butler Merlin G.2ORCID, Hossain Waheeda A.2, Castro-Magana Mariano1, Corletto Jorge1
Affiliation:
1. Department of Pediatrics , NYU Langone Hospital-Long Island , Mineola , NY , USA 2. Departments of Psychiatry & Behavioral Sciences , University of Kansas Medical Center , Kansas City , KS , USA
Abstract
Abstract
Objectives
Prader–Willi syndrome (PWS) is a complex genetic disorder with severe hypotonia, failure to thrive, childhood obesity, hypogonadism/hypogenitalism and learning/behavioral problems with endocrine-related growth and other hormone deficiencies. The prevalence of central adrenal insufficiency (CAI) using dynamic testing ranges from rare to 60%. We compared routine morning plasma cortisol (MPC) and ACTH levels in large cohorts of PWS and control children to address CAI.
Methods
Retrospective analysis of MPC and ACTH levels was undertaken in 128 PWS growth hormone (GH)-treated children under medical care before considering dynamic testing for CAI and 128 non-syndromic control children with short stature evaluated for GH deficiency.
Results
The average MPC level in PWS was 9.7 ± 3.7 μg/dL with no difference in age, gender or PWS genetic subtype and 13.4 ± 5.7 μg/dL in the control group. MPC levels were significantly lower (p < 0.05) in PWS but in the normal range. The morning plasma ACTH level in the PWS group was 22.1 ± 8.0 pg/mL with one individual having an initial low plasma ACTH level (8 pg/mL), but normal upon repeat.
Conclusions
MPC levels in PWS are normal and comparable with control children, without evidence or increased risk of CAI. Lower but normal MPC levels were seen in PWS and suggestive of reduced local regeneration of cortisol from cortisone in adipose tissue by the GH-IGF-I system. Hence, MPC measures alone or in combination with ACTH should be considered for initial screening for CAI in PWS but prior to dynamic testing.
Funder
National Institute of Child Health and Human Development
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference50 articles.
1. Vogels, A, Van Den Ende, J, Keymolen, K, Mortier, G, Devriendt, K, Legius, E, et al.. Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders. Eur J Hum Genet 2004;12:238–40. https://doi.org/10.1038/sj.ejhg.5201135. 2. Lionti, T, Reid, SM, White, SM, Rowell, MM. A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet 2015;167:371–8. https://doi.org/10.1002/ajmg.a.36845. 3. Angulo, MA, Butler, MG, Cataletto, ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 2015;38:1249–63. https://doi.org/10.1007/s40618-015-0312-9. 4. Butler, MG, Hartin, SN, Hossain, WA, Manzardo, A, Kimonis, V, Dykens, E, et al.. Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study. J Med Genet 2019;56:149–53. https://doi.org/10.1136/jmedgenet-2018-105301. 5. Angulo, M, Castro-Magana, M, Uy, J. Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrinol Metab 1991;4:167–73. https://doi.org/10.1515/jpem.1991.4.3.167.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|